Dimerix Ltd (ASX:DXB, OTC:SBMJF) has completed dosing the last adult patient in its ACTION3 Phase 3 trial of DMX-200 for focal segmental glomerulosclerosis (FSGS), with final adult enrolment reaching ...
6d
Jeffrey W. Sherman, MD, Joins DIMERx Board to Advance Next-Generation, Non-Addictive Pain Therapies
("DIMERx" or "the Company"), is a clinical-stage biopharmaceutical company dedicated to addressing the public-health crisis of drug abuse and dependence, with a portfolio of first-in-class, ...
Visiting students can Apply for the summer term. For better or worse humanity is heading down the virtual rabbit hole. We’re ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results